Global Insomnia Therapeutics Market 2026 - Players, Regions, Product Types, Application & Forecast Analysis

Chapter 1 Insomnia Therapeutics Market Overview

1.1 Insomnia Therapeutics Definition

1.2 Global Insomnia Therapeutics Market Size Status and Outlook (2019-2032)

1.3 Global Insomnia Therapeutics Market Size Comparison by Region (2019-2032)

1.4 Global Insomnia Therapeutics Market Size Comparison by Type (2019-2032)

1.5 Global Insomnia Therapeutics Market Size Comparison by Application (2019-2032)

1.6 Global Insomnia Therapeutics Market Size Comparison by Sales Channel (2019-2032)

1.7 Insomnia Therapeutics Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

1.7.6 US-Israel-Iran War Impacts

Chapter 2 Executive Summary

2.1 Global Insomnia Therapeutics Market Snapshot

2.2 Global Insomnia Therapeutics Market Volume & Revenue (2019-2025)

2.3 Global Insomnia Therapeutics Market Differential Growth Potential Analysis by Type, (2019-2032) (USD Million)

2.4 Global Insomnia Therapeutics Market Differential Growth Potential Analysis by Application, (2019-2032) (USD Million)

2.5 Global Insomnia Therapeutics Market Differential Growth Potential Analysis by Sales Channels, (2019-2032) (USD Million)

2.6 Global Insomnia Therapeutics Market Differential Growth Potential Analysis by Region, (2019-2032) (USD Million)

Chapter 3 Insomnia Therapeutics Market Segment Analysis by Player

3.1 Global Insomnia Therapeutics Sales and Market Share by Player (2023-2025)

3.2 Global Insomnia Therapeutics Revenue and Market Share by Player (2023-2025)

3.3 Global Insomnia Therapeutics Average Price by Player (2023-2025)

3.4 Players Competition Situation & Trends (2023-2025)

3.5 Conclusion of Segment by Player

Chapter 4 Insomnia Therapeutics Market Segment Analysis by Type

4.1 Global Insomnia Therapeutics Market by Type

4.1.1 Benzodiazepines

4.1.2 Nonbenzodiazepines

4.1.3 Antidepressants

4.1.4 Orexin Antagonists

4.1.5 Melatonin Antagonists

4.2 Global Insomnia Therapeutics Sales and Market Share by Type (2019-2025)

4.3 Global Insomnia Therapeutics Revenue and Market Share by Type (2019-2025)

4.4 Global Insomnia Therapeutics Average Price by Type (2019-2025)

4.5 Leading Players of Insomnia Therapeutics by Type in 2025

4.6 Conclusion of Segment by Type

Chapter 5 Insomnia Therapeutics Market Segment Analysis by Application

5.1 Global Insomnia Therapeutics Market by Application

5.1.1 Hospital Pharmacies

5.1.2 Retail Pharmacies

5.1.3 Online Pharmacies

5.2 Global Insomnia Therapeutics Revenue and Market Share by Application (2019-2025)

5.3 Leading Consumers of Insomnia Therapeutics by Application in 2025

5.4 Conclusion of Segment by Application

Chapter 6 Insomnia Therapeutics Market Segment Analysis by Sales Channel

6.1 Global Insomnia Therapeutics Market by Sales Channel

6.1.1 Global Insomnia Therapeutics Market, by Direct Channel Market Analysis (2019-2032) (USD Million)

6.1.2 Global Insomnia Therapeutics Market, by Distribution Channel Market Analysis (2019-2032) (USD Million)

6.2 Global Insomnia Therapeutics Revenue and Market Share by Sales Channel (2019-2025)

6.3 Leading Distributors/Dealers of Insomnia Therapeutics by Sales Channel in 2025

6.4 Conclusion of Segment by Sales Channel

Chapter 7 Insomnia Therapeutics Market Segment Analysis by Region

7.1 Global Insomnia Therapeutics Market Size and CAGR by Region (2019-2032)

7.2 Global Insomnia Therapeutics Sales and Market Share by Region (2019-2025)

7.3 Global Insomnia Therapeutics Revenue and Market Share by Region (2019-2025)

7.4 North America

7.4.1 North America Market by Country

7.4.2 North America Insomnia Therapeutics Market Share by Type

7.4.3 North America Insomnia Therapeutics Market Share by Application

7.4.4 United States

7.4.5 Canada

7.4.6 Mexico

7.5 Europe

7.5.1 Europe Market by Country

7.5.2 Europe Insomnia Therapeutics Market Share by Type

7.5.3 Europe Insomnia Therapeutics Market Share by Application

7.5.4 Germany

7.5.5 United Kingdom

7.5.6 France

7.5.7 Italy

7.5.8 Russia

7.5.9 Spain

7.5.10 Benelux

7.5.11 Poland

7.5.12 Austria

7.5.13 Portugal

7.5.14 Rest of Europe

7.6 Asia-Pacific

7.6.1 Asia-Pacific Market by Country

7.6.2 Asia-Pacific Insomnia Therapeutics Market Share by Type

7.6.3 Asia-Pacific Insomnia Therapeutics Market Share by Application

7.6.4 China

7.6.5 Japan

7.6.6 Korea

7.6.7 India

7.6.8 Southeast Asia

7.6.9 Australia

7.6.10 Taiwan

7.6.11 Rest of Asia Pacific

7.7 South America

7.7.1 South America Market by Country

7.7.2 South America Insomnia Therapeutics Market Share by Type

7.7.3 South America Insomnia Therapeutics Market Share by Application

7.7.4 Brazil

7.7.5 Argentina

7.7.6 Colombia

7.7.7 Chile

7.7.8 Peru

7.7.9 Venezuela

7.7.10 Rest of South America

7.8 Middle East & Africa

7.8.1 Middle East & Africa Market by Country

7.8.2 Middle East & Africa Insomnia Therapeutics Market Share by Type

7.8.3 Middle East & Africa Insomnia Therapeutics Market Share by Application

7.8.4 UAE

7.8.5 Saudi Arabia

7.8.6 South Africa

7.8.7 Egypt

7.8.8 Nigeria

7.9.9 Rest of Middle East & Africa

7.9 Conclusion of Segment by Region

Chapter 8 Profile of Leading Insomnia Therapeutics Players

8.1 Meda Consumer Healthcare

8.1.1 Company Snapshot

8.1.2 Product/Service Offered

8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.1.4 Recent Developments

8.2 Takeda Pharmaceuticals

8.2.1 Company Snapshot

8.2.2 Product/Service Offered

8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.2.4 Recent Developments

8.3 Pfizer

8.3.1 Company Snapshot

8.3.2 Product/Service Offered

8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.3.4 Recent Developments

8.4 Sanofi

8.4.1 Company Snapshot

8.4.2 Product/Service Offered

8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.4.4 Recent Developments

8.5 Vanda Pharmaceuticals

8.5.1 Company Snapshot

8.5.2 Product/Service Offered

8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.5.4 Recent Developments

8.6 Pernix Therapeutics

8.6.1 Company Snapshot

8.6.2 Product/Service Offered

8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.6.4 Recent Developments

8.7 Purdue Pharmaceuticals

8.7.1 Company Snapshot

8.7.2 Product/Service Offered

8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.7.4 Recent Developments

8.8 Mylan

8.8.1 Company Snapshot

8.8.2 Product/Service Offered

8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.8.4 Recent Developments

8.9 Teva Pharmaceutical

8.9.1 Company Snapshot

8.9.2 Product/Service Offered

8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.9.4 Recent Developments

8.10 Sumitomo Dainippon Pharma

8.10.1 Company Snapshot

8.10.2 Product/Service Offered

8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.10.4 Recent Developments

8.11 Paratek Pharmaceuticals

8.11.1 Company Snapshot

8.11.2 Product/Service Offered

8.11.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.11.4 Recent Developments

8.12 Ebb Therapeutics

8.12.1 Company Snapshot

8.12.2 Product/Service Offered

8.12.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.12.4 Recent Developments

8.13 Astellas

8.13.1 Company Snapshot

8.13.2 Product/Service Offered

8.13.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.13.4 Recent Developments

8.14 Dainippon Sumitomo

8.14.1 Company Snapshot

8.14.2 Product/Service Offered

8.14.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.14.4 Recent Developments

8.15 Flynn Pharma

8.15.1 Company Snapshot

8.15.2 Product/Service Offered

8.15.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.15.4 Recent Developments

8.16 Johnson & Johnson

8.16.1 Company Snapshot

8.16.2 Product/Service Offered

8.16.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.16.4 Recent Developments

8.17 Somnus Therapeutics

8.17.1 Company Snapshot

8.17.2 Product/Service Offered

8.17.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.17.4 Recent Developments

8.18 Neurim

8.18.1 Company Snapshot

8.18.2 Product/Service Offered

8.18.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.18.4 Recent Developments

8.19 Minerva Neurosciences

8.19.1 Company Snapshot

8.19.2 Product/Service Offered

8.19.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.19.4 Recent Developments

8.20 SkyePharma

8.20.1 Company Snapshot

8.20.2 Product/Service Offered

8.20.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.20.4 Recent Developments

Chapter 9 Upstream and Downstream Analysis of Insomnia Therapeutics

9.1 Industrial Chain of Insomnia Therapeutics

9.2 Upstream of Insomnia Therapeutics

9.2.1 Raw Materials (If Applicable)

9.2.2 Manufacturing Cost Structure (If Applicable)

9.2.3 Manufacturing Process (If Applicable)

9.3 Downstream of Insomnia Therapeutics

9.3.1 Leading Distributors/Dealers of Insomnia Therapeutics

9.3.2 Leading Consumers of Insomnia Therapeutics

Chapter 10. Global Insomnia Therapeutics Market Industry Analysis

10.1. Porter's Five Forces Analysis

10.1.1. Threat of New Entrants

10.1.2. Bargaining Power of Buyers/Consumers

10.1.3. Bargaining Power of Suppliers

10.1.4. Threat of Substitute Types

10.1.5. Intensity of Competitive Rivalry

10.2. Major Growth Avenues within Global Insomnia Therapeutics Market

10.2.1. Product Types

10.2.2. Applications

10.2.3. Sales Channels

10.2.4. Country

10.3. Insomnia Therapeutics Industry Ecosystem

10.4. Price Trend Analysis (If Applicable)

10.5. Buying Criteria (If Applicable)

10.6. Regulations (If Applicable)

Chapter 11 Development Trend of Insomnia Therapeutics (2026-2032)

11.1 Global Insomnia Therapeutics Market Size (Sales and Revenue) Forecast (2026-2032)

11.2 Global Insomnia Therapeutics Market Size and CAGR Forecast by Region (2026-2032)

11.3 Global Insomnia Therapeutics Market Size and CAGR Forecast by Type (2026-2032)

11.4 Global Insomnia Therapeutics Market Size and CAGR Forecast by Application (2026-2032)

11.5 Global Insomnia Therapeutics Market Size and CAGR Forecast by Sales Channel (2026-2032)

Chapter 12. Import - Export Analysis (If Applicable)

12.1 North America Insomnia Therapeutics Import-Export (2019-2025)

12.2 Europe Insomnia Therapeutics Import-Export (2019-2025)

12.3 Asia Pacific Insomnia Therapeutics Import-Export (2019-2025)

12.4 South America Insomnia Therapeutics Import-Export (2019-2025)

12.5 Middle East & Africa Insomnia Therapeutics Import-Export (2019-2025)

Chapter 13. Demand-Supply Gap Analysis

13.1 North America Insomnia Therapeutics Demand-Supply (2019-2025)

13.2 Europe Insomnia Therapeutics Demand-Supply (2019-2025)

13.3 Asia Pacific Insomnia Therapeutics Demand-Supply (2019-2025)

13.4 South America Insomnia Therapeutics Demand-Supply (2019-2025)

13.5 Middle East & Africa Insomnia Therapeutics Demand-Supply (2019-2025)

Chapter 14 Appendix

14.1 Research Methodology

14.2 Data Sources